Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Quick facts

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Karuna Therapeutics, Inc., a Bristol Myers Squibb company portfolio CI brief
• Karuna Therapeutics, Inc., a Bristol Myers Squibb company pipeline updates RSS